Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Jay Olson's Stock Ratings
Oppenheimer Analyst
Jay Olson is an analyst at Oppenheimer. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
14.5%
Smart Score
Overall Average Return Percentile
68th
Number of Ratings
317
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11/20/2025 | MDGL | Buy Now | Madrigal Pharmaceuticals | $560.55 | 15.96% | $600 → $650 | Maintains | Outperform | Get Alert | |
| 10/10/2025 | MDGL | Buy Now | Madrigal Pharmaceuticals | $560.55 | 5.25% | $500 → $590 | Maintains | Outperform | Get Alert | |
| 10/08/2025 | IONS | Buy Now | Ionis Pharmaceuticals | $79.76 | 12.84% | $84 → $90 | Maintains | Outperform | Get Alert | |
| 09/25/2025 | IMRX | Buy Now | Immuneering | $5.83 | 414.58% | $21 → $30 | Maintains | Outperform | Get Alert | |
| 08/11/2025 | BCYC | Buy Now | Bicycle Therapeutics | $7.40 | 494.59% | $48 → $44 | Maintains | Outperform | Get Alert | |
| 06/26/2025 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.02 | -18.57% | $19 → $22 | Maintains | Perform | Get Alert | |
| 05/27/2025 | PRTA | Buy Now | Prothena Corp | $9.97 | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 05/15/2025 | JSPR | Buy Now | Jasper Therapeutics | $1.60 | 3959.46% | $80 → $65 | Maintains | Outperform | Get Alert | |
| 05/14/2025 | INO | Buy Now | Inovio Pharmaceuticals | $2.27 | 472.69% | $15 → $13 | Maintains | Outperform | Get Alert | |
| 05/08/2025 | RVMD | Buy Now | Revolution Medicines | $77.51 | -3.24% | $70 → $75 | Maintains | Outperform | Get Alert | |
| 05/07/2025 | IMRX | Buy Now | Immuneering | $5.83 | 260.21% | $25 → $21 | Maintains | Outperform | Get Alert | |
| 03/14/2025 | NKTR | Buy Now | Nektar Therapeutics | $58.80 | -89.8% | → $6 | Upgrade | Perform → Outperform | Get Alert | |
| 03/03/2025 | DNLI | Buy Now | Denali Therapeutics | $17.20 | 144.19% | $50 → $42 | Maintains | Outperform | Get Alert | |
| 02/07/2025 | PRTA | Buy Now | Prothena Corp | $9.97 | 521.87% | $58 → $62 | Maintains | Outperform | Get Alert | |
| 01/24/2025 | EXEL | Buy Now | Exelixis | $41.63 | -20.72% | $41 → $33 | Downgrade | Outperform → Perform | Get Alert | |
| 01/16/2025 | EXEL | Buy Now | Exelixis | $41.63 | -1.5% | $38 → $41 | Maintains | Outperform | Get Alert | |
| 01/13/2025 | NTLA | Buy Now | Intellia Therapeutics | $9.15 | 337.25% | $60 → $40 | Maintains | Outperform | Get Alert | |
| 12/19/2024 | PRTA | Buy Now | Prothena Corp | $9.97 | 481.75% | $62 → $58 | Maintains | Outperform | Get Alert | |
| 12/11/2024 | QTTB | Buy Now | Q32 Bio | $2.93 | 583.5% | $80 → $20 | Maintains | Outperform | Get Alert | |
| 11/18/2024 | INO | Buy Now | Inovio Pharmaceuticals | $2.27 | 560.79% | $33 → $15 | Maintains | Outperform | Get Alert | |
| 11/11/2024 | NTLA | Buy Now | Intellia Therapeutics | $9.15 | 555.88% | $70 → $60 | Maintains | Outperform | Get Alert | |
| 10/31/2024 | BIIB | Buy Now | Biogen | $175.74 | 45.1% | $270 → $255 | Maintains | Outperform | Get Alert | |
| 10/30/2024 | SAGE | Buy Now | Sage Therapeutics | — | — | $9 → $8 | Maintains | Perform | Get Alert | |
| 10/30/2024 | INCY | Buy Now | Incyte | $99.08 | -17.24% | $81 → $82 | Maintains | Outperform | Get Alert | |
| 10/28/2024 | RVMD | Buy Now | Revolution Medicines | $77.51 | -22.59% | $55 → $60 | Maintains | Outperform | Get Alert | |
| 10/23/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $560.55 | -37.56% | $375 → $350 | Maintains | Outperform | Get Alert | |
| 10/17/2024 | GLTO | Buy Now | Galecto | $31.68 | -68.43% | $9 → $10 | Maintains | Outperform | Get Alert | |
| 09/25/2024 | VKTX | Buy Now | Viking Therapeutics | $36.24 | 280.79% | $138 → $138 | Reiterates | Outperform → Outperform | Get Alert | |
| 09/23/2024 | MRNS | Buy Now | Marinus Pharma | — | — | → $6 | Upgrade | Perform → Outperform | Get Alert | |
| 08/14/2024 | PRTA | Buy Now | Prothena Corp | $9.97 | 521.87% | $66 → $62 | Maintains | Outperform | Get Alert | |
| 08/14/2024 | GANX | Buy Now | Gain Therapeutics | $4.01 | 99.4% | → $8 | Assumes | → Outperform | Get Alert | |
| 08/12/2024 | INO | Buy Now | Inovio Pharmaceuticals | $2.27 | 1353.74% | $40 → $33 | Maintains | Outperform | Get Alert | |
| 08/07/2024 | BCYC | Buy Now | Bicycle Therapeutics | $7.40 | 548.65% | $48 → $48 | Maintains | Outperform | Get Alert | |
| 08/07/2024 | AMGN | Buy Now | Amgen | $324.50 | 17.1% | $380 → $380 | Maintains | Outperform | Get Alert | |
| 08/02/2024 | NBIX | Buy Now | Neurocrine Biosciences | $155.00 | 41.29% | $216 → $219 | Maintains | Outperform | Get Alert | |
| 07/30/2024 | EXEL | Buy Now | Exelixis | $41.63 | -30.33% | $29 → $29 | Maintains | Outperform | Get Alert | |
| 07/26/2024 | INCY | Buy Now | Incyte | $99.08 | -18.25% | $84 → $81 | Maintains | Outperform | Get Alert | |
| 07/16/2024 | RVMD | Buy Now | Revolution Medicines | $77.51 | -29.04% | $45 → $55 | Maintains | Outperform | Get Alert | |
| 06/18/2024 | EDIT | Buy Now | Editas Medicine | $2.49 | 382.1% | $12 → $12 | Maintains | Perform | Get Alert | |
| 06/10/2024 | GLTO | Buy Now | Galecto | $31.68 | -71.59% | $10 → $9 | Maintains | Outperform | Get Alert | |
| 05/15/2024 | VYGR | Buy Now | Voyager Therapeutics | $4.28 | 320.56% | $18 → $18 | Maintains | Outperform | Get Alert | |
| 05/15/2024 | STRO | Buy Now | Sutro Biopharma | $9.74 | 2.67% | $10 → $10 | Maintains | Outperform | Get Alert | |
| 05/10/2024 | CRSP | Buy Now | CRISPR Therapeutics | $56.00 | 69.64% | $102 → $95 | Maintains | Outperform | Get Alert | |
| 05/06/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.02 | -29.67% | $19 → $19 | Maintains | Perform | Get Alert | |
| 05/02/2024 | NBIX | Buy Now | Neurocrine Biosciences | $155.00 | 39.35% | $200 → $216 | Maintains | Outperform | Get Alert | |
| 04/29/2024 | BIIB | Buy Now | Biogen | $175.74 | 53.64% | $270 → $270 | Maintains | Outperform | Get Alert | |
| 04/24/2024 | NBIX | Buy Now | Neurocrine Biosciences | $155.00 | 29.03% | $200 → $200 | Maintains | Outperform | Get Alert | |
| 04/24/2024 | INCY | Buy Now | Incyte | $99.08 | -15.22% | $92 → $84 | Maintains | Outperform | Get Alert | |
| 04/19/2024 | BIIB | Buy Now | Biogen | $175.74 | 53.64% | $290 → $270 | Maintains | Outperform | Get Alert | |
| 04/18/2024 | SAGE | Buy Now | Sage Therapeutics | — | — | $25 → $17 | Maintains | Perform | Get Alert | |
| 04/12/2024 | RVMD | Buy Now | Revolution Medicines | $77.51 | -41.94% | $43 → $45 | Maintains | Outperform | Get Alert | |
| 04/12/2024 | SKYE | Buy Now | Skye Bioscience | $1.07 | 2236.45% | → $25 | Initiates | → Outperform | Get Alert | |
| 04/11/2024 | QTTB | Buy Now | Q32 Bio | $2.93 | 1608.76% | → $50 | Initiates | → Outperform | Get Alert | |
| 04/09/2024 | IONS | Buy Now | Ionis Pharmaceuticals | $79.76 | -5.97% | $72 → $75 | Maintains | Outperform | Get Alert | |
| 04/03/2024 | STRO | Buy Now | Sutro Biopharma | $9.74 | 2.67% | $10 → $10 | Maintains | Outperform | Get Alert | |
| 03/28/2024 | STRO | Buy Now | Sutro Biopharma | $9.74 | 2.67% | → $10 | Maintains | Outperform | Get Alert | |
| 03/27/2024 | VKTX | Buy Now | Viking Therapeutics | $36.24 | 280.79% | $116 → $138 | Maintains | Outperform | Get Alert | |
| 03/27/2024 | STRO | Buy Now | Sutro Biopharma | $9.74 | 2.67% | $10 → $10 | Maintains | Outperform | Get Alert | |
| 03/27/2024 | CGTX | Buy Now | Cognition Therapeutics | $1.65 | 445.45% | $9 → $9 | Maintains | Outperform | Get Alert | |
| 03/26/2024 | VKTX | Buy Now | Viking Therapeutics | $36.24 | 280.79% | $116 → $138 | Maintains | Outperform | Get Alert | |
| 03/15/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $560.55 | -33.1% | $320 → $375 | Maintains | Outperform | Get Alert | |
| 03/13/2024 | NBIX | Buy Now | Neurocrine Biosciences | $155.00 | 29.03% | $170 → $200 | Maintains | Outperform | Get Alert | |
| 03/12/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.02 | -29.67% | $25 → $19 | Maintains | Perform | Get Alert | |
| 03/07/2024 | MRNS | Buy Now | Marinus Pharma | — | — | $9 → $9 | Maintains | Perform | Get Alert | |
| 03/07/2024 | JSPR | Buy Now | Jasper Therapeutics | $1.60 | 4896.25% | $80 → $80 | Maintains | Outperform | Get Alert | |
| 03/06/2024 | IONS | Buy Now | Ionis Pharmaceuticals | $79.76 | -9.73% | $65 → $72 | Maintains | Outperform | Get Alert | |
| 03/05/2024 | IMRX | Buy Now | Immuneering | $5.83 | 328.82% | $25 → $25 | Reiterates | Outperform → Outperform | Get Alert | |
| 03/05/2024 | ETNB | Buy Now | 89bio | — | — | — | Maintains | Perform | Get Alert | |
| 03/01/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $560.55 | -42.91% | $300 → $320 | Maintains | Outperform | Get Alert | |
| 02/28/2024 | VKTX | Buy Now | Viking Therapeutics | $36.24 | 220.09% | $46 → $116 | Maintains | Outperform | Get Alert | |
| 02/26/2024 | IONS | Buy Now | Ionis Pharmaceuticals | $79.76 | -18.51% | $63 → $65 | Reinstates | → Outperform | Get Alert | |
| 02/20/2024 | PRTA | Buy Now | Prothena Corp | $9.97 | 702.41% | $98 → $80 | Maintains | Outperform | Get Alert | |
| 02/14/2024 | BIIB | Buy Now | Biogen | $175.74 | 65.02% | $295 → $290 | Maintains | Outperform | Get Alert | |
| 02/05/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.02 | -7.47% | → $25 | Reiterates | Perform → Perform | Get Alert | |
| 02/01/2024 | AMGN | Buy Now | Amgen | $324.50 | 7.86% | $350 → $350 | Reiterates | Outperform → Outperform | Get Alert | |
| 01/30/2024 | BIIB | Buy Now | Biogen | $175.74 | 67.86% | → $295 | Reiterates | Outperform → Outperform | Get Alert | |
| 12/18/2023 | BIIB | Buy Now | Biogen | $175.74 | 67.86% | $280 → $295 | Maintains | Outperform | Get Alert | |
| 11/30/2023 | BIVI | Buy Now | BioVie | $1.37 | 264.94% | $12 → $5 | Maintains | Outperform | Get Alert | |
| 11/22/2023 | ENTA | Buy Now | Enanta Pharma | $14.87 | 41.22% | $25 → $21 | Maintains | Perform | Get Alert | |
| 11/13/2023 | NTLA | Buy Now | Intellia Therapeutics | $9.15 | 665.19% | $80 → $70 | Maintains | Outperform | Get Alert | |
| 10/25/2023 | AMGN | Buy Now | Amgen | $324.50 | -4.47% | $300 → $310 | Maintains | Outperform | Get Alert | |
| 10/23/2023 | RVMD | Buy Now | Revolution Medicines | $77.51 | -44.52% | $40 → $43 | Maintains | Outperform | Get Alert | |
| 10/20/2023 | AMGN | Buy Now | Amgen | $324.50 | -7.55% | $290 → $300 | Maintains | Outperform | Get Alert | |
| 10/09/2023 | AMGN | Buy Now | Amgen | $324.50 | -10.63% | $280 → $290 | Maintains | Outperform | Get Alert | |
| 10/06/2023 | NBIX | Buy Now | Neurocrine Biosciences | $155.00 | 6.45% | $160 → $165 | Maintains | Outperform | Get Alert | |
| 10/06/2023 | IMGN | Buy Now | Immunogen | — | — | → $16 | Initiates | → Perform | Get Alert | |
| 10/06/2023 | STRO | Buy Now | Sutro Biopharma | $9.74 | 2.67% | → $10 | Initiates | → Outperform | Get Alert | |
| 08/22/2023 | EXEL | Buy Now | Exelixis | $41.63 | -30.33% | $25 → $29 | Maintains | Outperform | Get Alert | |
| 08/21/2023 | NBIX | Buy Now | Neurocrine Biosciences | $155.00 | -0.65% | $150 → $154 | Maintains | Outperform | Get Alert | |
| 08/11/2023 | MRNS | Buy Now | Marinus Pharma | — | — | → $14 | Downgrade | Outperform → Perform | Get Alert | |
| 08/10/2023 | CRSP | Buy Now | CRISPR Therapeutics | $56.00 | 82.14% | → $102 | Reiterates | Outperform → Outperform | Get Alert | |
| 08/09/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | $56 → $62 | Maintains | Outperform | Get Alert | |
| 08/09/2023 | MDGL | Buy Now | Madrigal Pharmaceuticals | $560.55 | -49.16% | $350 → $285 | Maintains | Outperform | Get Alert | |
| 08/09/2023 | ENTA | Buy Now | Enanta Pharma | $14.87 | 68.12% | $30 → $25 | Maintains | Perform | Get Alert | |
| 08/08/2023 | SAGE | Buy Now | Sage Therapeutics | — | — | $24 → $20 | Maintains | Perform | Get Alert | |
| 08/07/2023 | VYGR | Buy Now | Voyager Therapeutics | $4.28 | 273.83% | → $16 | Reiterates | Outperform → Outperform | Get Alert | |
| 08/07/2023 | BIIB | Buy Now | Biogen | $175.74 | 65.02% | $360 → $290 | Maintains | Outperform | Get Alert | |
| 08/07/2023 | SAGE | Buy Now | Sage Therapeutics | — | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 08/03/2023 | EDIT | Buy Now | Editas Medicine | $2.49 | 382.1% | → $12 | Reiterates | Perform → Perform | Get Alert | |
| 08/03/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.02 | -7.47% | → $25 | Reiterates | Perform → Perform | Get Alert | |
| 08/02/2023 | RVMD | Buy Now | Revolution Medicines | $77.51 | -48.39% | $35 → $40 | Maintains | Outperform | Get Alert | |
| 08/02/2023 | NBIX | Buy Now | Neurocrine Biosciences | $155.00 | -3.23% | → $150 | Reiterates | Outperform → Outperform | Get Alert | |
| 08/02/2023 | INCY | Buy Now | Incyte | $99.08 | -7.15% | → $92 | Reiterates | Outperform → Outperform | Get Alert | |
| 08/01/2023 | GLTO | Buy Now | Galecto | $31.68 | -62.12% | → $12 | Reiterates | Outperform → Outperform | Get Alert | |
| 07/31/2023 | EXEL | Buy Now | Exelixis | $41.63 | -39.94% | → $25 | Reiterates | Outperform → Outperform | Get Alert | |
| 07/28/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.02 | -7.47% | $23 → $25 | Maintains | Perform | Get Alert | |
| 07/25/2023 | AMGN | Buy Now | Amgen | $324.50 | -13.71% | $280 → $280 | Reiterates | Outperform → Outperform | Get Alert | |
| 07/14/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.02 | -14.87% | $20 → $23 | Maintains | Perform | Get Alert | |
| 06/20/2023 | GLTO | Buy Now | Galecto | $31.68 | -62.12% | → $12 | Initiates | → Outperform | Get Alert | |
| 06/12/2023 | BIIB | Buy Now | Biogen | $175.74 | 104.85% | $350 → $360 | Maintains | Outperform | Get Alert | |
| 06/06/2023 | DNLI | Buy Now | Denali Therapeutics | $17.20 | 295.35% | $70 → $68 | Maintains | Outperform | Get Alert | |
| 05/18/2023 | AMGN | Buy Now | Amgen | $324.50 | -13.71% | $280 → $280 | Reiterates | Outperform → Outperform | Get Alert | |
| 05/17/2023 | BIVI | Buy Now | BioVie | $1.37 | 775.85% | → $12 | Reiterates | Outperform → Outperform | Get Alert | |
| 05/16/2023 | VKTX | Buy Now | Viking Therapeutics | $36.24 | 10.38% | $35 → $40 | Maintains | Outperform | Get Alert | |
| 05/16/2023 | JSPR | Buy Now | Jasper Therapeutics | $1.60 | 399.63% | → $8 | Reinstates | Outperform → Outperform | Get Alert | |
| 05/16/2023 | CBAY | Buy Now | CymaBay Therapeutics | — | — | $14 → $16 | Maintains | Outperform | Get Alert | |
| 05/16/2023 | MDGL | Buy Now | Madrigal Pharmaceuticals | $560.55 | -37.56% | $300 → $350 | Maintains | Outperform | Get Alert | |
| 05/11/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | → $60 | Reiterates | Perform → Perform | Get Alert | |
| 05/11/2023 | ENTA | Buy Now | Enanta Pharma | $14.87 | 101.75% | $50 → $30 | Reiterates | Perform → Perform | Get Alert | |
| 05/11/2023 | ETNB | Buy Now | 89bio | — | — | → $30 | Reiterates | Outperform → Outperform | Get Alert | |
| 05/09/2023 | RVMD | Buy Now | Revolution Medicines | $77.51 | -54.84% | → $35 | Reiterates | → Outperform | Get Alert | |
| 05/09/2023 | EDIT | Buy Now | Editas Medicine | $2.49 | 382.1% | → $12 | Reiterates | → Perform | Get Alert | |
| 05/09/2023 | CGTX | Buy Now | Cognition Therapeutics | $1.65 | 445.45% | → $9 | Reiterates | → Outperform | Get Alert | |
| 05/08/2023 | BCYC | Buy Now | Bicycle Therapeutics | $7.40 | 643.24% | $55 → $55 | Reiterates | Outperform → Outperform | Get Alert | |
| 05/08/2023 | KRTX | Buy Now | Karuna Therapeutics | — | — | → $280 | Reiterates | → Outperform | Get Alert | |
| 05/08/2023 | NTLA | Buy Now | Intellia Therapeutics | $9.15 | 883.82% | $93 → $90 | Maintains | Outperform | Get Alert | |
| 05/02/2023 | NBIX | Buy Now | Neurocrine Biosciences | $155.00 | -3.23% | → $150 | Reiterates | → Outperform | Get Alert | |
| 04/27/2023 | VKTX | Buy Now | Viking Therapeutics | $36.24 | -3.42% | → $35 | Reiterates | → Outperform | Get Alert | |
| 04/26/2023 | BIIB | Buy Now | Biogen | $175.74 | 84.93% | $310 → $325 | Maintains | Outperform | Get Alert | |
| 04/25/2023 | MRNS | Buy Now | Marinus Pharma | — | — | $12 → $14 | Maintains | Outperform | Get Alert | |
| 04/25/2023 | VKTX | Buy Now | Viking Therapeutics | $36.24 | -3.42% | $30 → $35 | Maintains | Outperform | Get Alert | |
| 04/24/2023 | AMGN | Buy Now | Amgen | $324.50 | -10.63% | $292 → $290 | Maintains | Outperform | Get Alert | |
| 03/28/2023 | VKTX | Buy Now | Viking Therapeutics | $36.24 | -17.22% | $20 → $30 | Maintains | Outperform | Get Alert | |
| 03/24/2023 | CGTX | Buy Now | Cognition Therapeutics | $1.65 | 445.45% | → $9 | Reiterates | → Outperform | Get Alert | |
| 03/14/2023 | SGEN | Buy Now | Seagen | — | — | $210 → $229 | Maintains | Outperform | Get Alert | |
| 03/10/2023 | VYGR | Buy Now | Voyager Therapeutics | $4.28 | 227.1% | → $14 | Initiates | → Outperform | Get Alert | |
| 03/07/2023 | CBAY | Buy Now | CymaBay Therapeutics | — | — | $10 → $12 | Maintains | Outperform | Get Alert | |
| 03/06/2023 | NKTR | Buy Now | Nektar Therapeutics | $58.80 | -94.9% | $5 → $3 | Maintains | Perform | Get Alert | |
| 03/02/2023 | DNLI | Buy Now | Denali Therapeutics | $17.20 | 306.98% | $85 → $70 | Maintains | Outperform | Get Alert | |
| 03/01/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.02 | -25.97% | $17 → $20 | Maintains | Perform | Get Alert | |
| 02/28/2023 | SGEN | Buy Now | Seagen | — | — | $180 → $210 | Maintains | Outperform | Get Alert | |
| 02/28/2023 | RVMD | Buy Now | Revolution Medicines | $77.51 | -54.84% | $30 → $35 | Maintains | Outperform | Get Alert | |
| 02/27/2023 | MDGL | Buy Now | Madrigal Pharmaceuticals | $560.55 | -46.48% | $250 → $300 | Maintains | Outperform | Get Alert | |
| 02/24/2023 | NTLA | Buy Now | Intellia Therapeutics | $9.15 | 916.62% | $115 → $93 | Maintains | Outperform | Get Alert | |
| 02/23/2023 | CRSP | Buy Now | CRISPR Therapeutics | $56.00 | 82.25% | $110 → $102.06 | Maintains | Outperform | Get Alert | |
| 02/21/2023 | SGEN | Buy Now | Seagen | — | — | $178 → $180 | Maintains | Outperform | Get Alert | |
| 02/21/2023 | ETNB | Buy Now | 89bio | — | — | $12 → $18 | Maintains | Outperform | Get Alert | |
| 02/17/2023 | SGEN | Buy Now | Seagen | — | — | $178 → $180 | Maintains | Outperform | Get Alert | |
| 02/16/2023 | BIIB | Buy Now | Biogen | $175.74 | 76.4% | $320 → $310 | Maintains | Outperform | Get Alert | |
| 02/15/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.02 | -37.08% | $16 → $17 | Maintains | Perform | Get Alert | |
| 02/14/2023 | BIVI | Buy Now | BioVie | $1.37 | 775.85% | → $12 | Reiterates | → Outperform | Get Alert | |
| 02/14/2023 | FREQ | Buy Now | Frequency Therapeutics | — | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 02/10/2023 | SGEN | Buy Now | Seagen | — | — | $188 → $178 | Maintains | Outperform | Get Alert | |
| 02/01/2023 | AMGN | Buy Now | Amgen | $324.50 | -9.4% | $312 → $294 | Maintains | Outperform | Get Alert | |
| 12/20/2022 | MDGL | Buy Now | Madrigal Pharmaceuticals | $560.55 | -55.4% | $170 → $250 | Maintains | Outperform | Get Alert | |
| 12/08/2022 | MRTX | Buy Now | Mirati Therapeutics | — | — | $85 → $60 | Maintains | Perform | Get Alert | |
| 12/06/2022 | AMGN | Buy Now | Amgen | $324.50 | -4.47% | $300 → $310 | Maintains | Outperform | Get Alert | |
| 11/29/2022 | CINC | Buy Now | CinCor Pharma | — | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 11/18/2022 | EDIT | Buy Now | Editas Medicine | $2.49 | 382.1% | $28 → $12 | Downgrade | Outperform → Perform | Get Alert | |
| 11/14/2022 | JSPR | Buy Now | Jasper Therapeutics | $1.60 | 399.63% | $21 → $8 | Maintains | Outperform | Get Alert | |
| 11/14/2022 | BIIB | Buy Now | Biogen | $175.74 | 79.24% | $300 → $315 | Maintains | Outperform | Get Alert | |
| 10/31/2022 | AYLA | Buy Now | Ayala Pharmaceuticals | — | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 10/28/2022 | SGEN | Buy Now | Seagen | — | — | $208 → $188 | Maintains | Outperform | Get Alert | |
| 10/21/2022 | RVMD | Buy Now | Revolution Medicines | $77.51 | -61.3% | → $30 | Initiates | → Outperform | Get Alert | |
| 10/13/2022 | RLMD | Buy Now | Relmada Therapeutics | $4.05 | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 09/29/2022 | PRTA | Buy Now | Prothena Corp | $9.97 | 1003.31% | $100 → $110 | Maintains | Outperform | Get Alert | |
| 08/10/2022 | ENTA | Buy Now | Enanta Pharma | $14.87 | 296.77% | $53 → $59 | Maintains | Perform | Get Alert | |
| 08/01/2022 | ENTA | Buy Now | Enanta Pharma | $14.87 | 256.42% | $45 → $53 | Maintains | Perform | Get Alert | |
| 07/21/2022 | CINC | Buy Now | CinCor Pharma | — | — | $30 → $35 | Maintains | Outperform | Get Alert | |
| 07/18/2022 | BIIB | Buy Now | Biogen | $175.74 | 30.88% | $225 → $230 | Maintains | Outperform | Get Alert | |
| 06/30/2022 | ETNB | Buy Now | 89bio | — | — | $40 → $15 | Maintains | Outperform | Get Alert | |
| 06/23/2022 | CRSP | Buy Now | CRISPR Therapeutics | $56.00 | 117.86% | $150 → $122 | Maintains | Outperform | Get Alert | |
| 06/21/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.02 | -29.67% | $23 → $19 | Maintains | Perform | Get Alert | |
| 06/21/2022 | SGEN | Buy Now | Seagen | — | — | $160 → $208 | Maintains | Outperform | Get Alert | |
| 06/01/2022 | AMGN | Buy Now | Amgen | $324.50 | -10.63% | $285 → $290 | Maintains | Outperform | Get Alert | |
| 05/20/2022 | ENTA | Buy Now | Enanta Pharma | $14.87 | 202.62% | $70 → $45 | Maintains | Outperform | Get Alert | |
| 05/13/2022 | ETNB | Buy Now | 89bio | — | — | $49 → $40 | Maintains | Outperform | Get Alert | |
| 05/11/2022 | CRSP | Buy Now | CRISPR Therapeutics | $56.00 | 167.86% | $172 → $150 | Maintains | Outperform | Get Alert | |
| 05/10/2022 | MDGL | Buy Now | Madrigal Pharmaceuticals | $560.55 | -69.67% | $180 → $170 | Maintains | Outperform | Get Alert | |
| 05/09/2022 | NTLA | Buy Now | Intellia Therapeutics | $9.15 | 1321.08% | $160 → $130 | Maintains | Outperform | Get Alert | |
| 05/09/2022 | RLMD | Buy Now | Relmada Therapeutics | $4.05 | 1480.25% | $75 → $64 | Maintains | Outperform | Get Alert | |
| 05/04/2022 | BIIB | Buy Now | Biogen | $175.74 | 28.03% | $240 → $225 | Maintains | Outperform | Get Alert | |
| 04/14/2022 | SRRA | Buy Now | Sierra Oncology | — | — | $45 → $55 | Downgrade | Outperform → Perform | Get Alert | |
| 04/08/2022 | BIIB | Buy Now | Biogen | $175.74 | 36.57% | $285 → $240 | Maintains | Outperform | Get Alert | |
| 03/30/2022 | AYLA | Buy Now | Ayala Pharmaceuticals | — | — | $25 → $16 | Maintains | Outperform | Get Alert | |
| 03/15/2022 | BIVI | Buy Now | BioVie | $1.37 | 556.89% | → $9 | Initiates | → Outperform | Get Alert | |
| 03/14/2022 | SRRA | Buy Now | Sierra Oncology | — | — | $38 → $45 | Maintains | Outperform | Get Alert | |
| 03/09/2022 | NKTR | Buy Now | Nektar Therapeutics | $58.80 | -64.29% | → $21 | Upgrade | Perform → Outperform | Get Alert | |
| 02/25/2022 | EDIT | Buy Now | Editas Medicine | $2.49 | 2109.63% | $80 → $55 | Maintains | Outperform | Get Alert | |
| 02/09/2022 | AMGN | Buy Now | Amgen | $324.50 | -12.17% | $272 → $285 | Maintains | Outperform | Get Alert | |
| 02/07/2022 | NTLA | Buy Now | Intellia Therapeutics | $9.15 | 1539.7% | $145 → $150 | Upgrade | Perform → Outperform | Get Alert | |
| 02/01/2022 | CINC | Buy Now | CinCor Pharma | — | — | → $30 | Initiates | → Outperform | Get Alert | |
| 12/22/2021 | BIIB | Buy Now | Biogen | $175.74 | 99.16% | $390 → $350 | Maintains | Outperform | Get Alert | |
| 12/09/2021 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.02 | -14.87% | $20 → $23 | Maintains | Perform | Get Alert | |
| 12/08/2021 | NBIX | Buy Now | Neurocrine Biosciences | $155.00 | -0.65% | $140 → $154 | Maintains | Outperform | Get Alert | |
| 12/07/2021 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.02 | -14.87% | $20 → $23 | Maintains | Perform | Get Alert | |
| 11/24/2021 | ENTA | Buy Now | Enanta Pharma | $14.87 | 390.92% | $55 → $73 | Maintains | Perform | Get Alert | |
| 11/05/2021 | NKTR | Buy Now | Nektar Therapeutics | $58.80 | -64.29% | $25 → $21 | Maintains | Perform | Get Alert | |
| 11/05/2021 | NTLA | Buy Now | Intellia Therapeutics | $9.15 | 1485.05% | $160 → $145 | Maintains | Perform | Get Alert | |
| 11/03/2021 | SAGE | Buy Now | Sage Therapeutics | — | — | $84 → $80 | Maintains | Outperform | Get Alert | |
| 11/03/2021 | INCY | Buy Now | Incyte | $99.08 | 10.01% | $110 → $109 | Maintains | Outperform | Get Alert | |
| 11/03/2021 | CGTX | Buy Now | Cognition Therapeutics | $1.65 | 1233.33% | → $22 | Initiates | → Outperform | Get Alert | |
| 11/02/2021 | EXEL | Buy Now | Exelixis | $41.63 | -30.33% | $30 → $29 | Maintains | Outperform | Get Alert | |
| 10/29/2021 | SGEN | Buy Now | Seagen | — | — | $196 → $198 | Maintains | Outperform | Get Alert | |
| 10/21/2021 | BIIB | Buy Now | Biogen | $175.74 | 121.92% | $450 → $390 | Maintains | Outperform | Get Alert | |
| 10/20/2021 | SAGE | Buy Now | Sage Therapeutics | — | — | $100 → $84 | Maintains | Outperform | Get Alert | |
| 10/13/2021 | FOCS | Buy Now | Focus Finl Partners | — | — | $64 → $71 | Maintains | Outperform | Get Alert | |
| 10/13/2021 | JSPR | Buy Now | Jasper Therapeutics | $1.60 | 1211.52% | → $21 | Initiates | → Outperform | Get Alert | |
| 09/27/2021 | PRTA | Buy Now | Prothena Corp | $9.97 | 903.01% | $90 → $100 | Maintains | Outperform | Get Alert | |
| 09/21/2021 | MRTX | Buy Now | Mirati Therapeutics | — | — | $160 → $175 | Maintains | Perform | Get Alert | |
| 09/21/2021 | DNLI | Buy Now | Denali Therapeutics | $17.20 | 394.19% | → $85 | Initiates | → Outperform | Get Alert | |
| 09/14/2021 | PRTA | Buy Now | Prothena Corp | $9.97 | 802.71% | $82 → $90 | Maintains | Outperform | Get Alert | |
| 09/10/2021 | EDIT | Buy Now | Editas Medicine | $2.49 | 3114.01% | $42 → $80 | Upgrade | Perform → Outperform | Get Alert | |
| 08/17/2021 | AYLA | Buy Now | Ayala Pharmaceuticals | — | — | $27 → $25 | Maintains | Outperform | Get Alert | |
| 08/09/2021 | PRTA | Buy Now | Prothena Corp | $9.97 | 722.47% | $76 → $82 | Maintains | Outperform | Get Alert | |
| 08/06/2021 | NTLA | Buy Now | Intellia Therapeutics | $9.15 | 1649.02% | $125 → $160 | Maintains | Perform | Get Alert | |
| 07/13/2021 | PRTA | Buy Now | Prothena Corp | $9.97 | 662.29% | $54 → $76 | Maintains | Outperform | Get Alert | |
| 06/07/2021 | AMGN | Buy Now | Amgen | $324.50 | -14.64% | $272 → $277 | Maintains | Outperform | Get Alert | |
| 05/18/2021 | BIIB | Buy Now | Biogen | $175.74 | 84.93% | $300 → $325 | Maintains | Outperform | Get Alert | |
| 05/17/2021 | MRTX | Buy Now | Mirati Therapeutics | — | — | $245 → $160 | Downgrade | Outperform → Perform | Get Alert | |
| 05/03/2021 | AMGN | Buy Now | Amgen | $324.50 | -18.34% | $275 → $265 | Maintains | Outperform | Get Alert | |
| 04/05/2021 | AMGN | Buy Now | Amgen | $324.50 | -15.25% | $266 → $275 | Maintains | Outperform | Get Alert | |
| 03/24/2021 | FREQ | Buy Now | Frequency Therapeutics | — | — | $68 → $20 | Maintains | Outperform | Get Alert | |
| 03/01/2021 | MRTX | Buy Now | Mirati Therapeutics | — | — | $260 → $255 | Maintains | Outperform | Get Alert | |
| 03/01/2021 | KRTX | Buy Now | Karuna Therapeutics | — | — | $135 → $148 | Maintains | Outperform | Get Alert | |
| 02/25/2021 | SAGE | Buy Now | Sage Therapeutics | — | — | $90 → $102 | Maintains | Outperform | Get Alert | |
| 02/17/2021 | CRSP | Buy Now | CRISPR Therapeutics | $56.00 | 233.93% | $165 → $187 | Maintains | Outperform | Get Alert | |
| 02/02/2021 | PRTA | Buy Now | Prothena Corp | $9.97 | 251.05% | $25 → $35 | Maintains | Outperform | Get Alert | |
| 11/11/2020 | VYGR | Buy Now | Voyager Therapeutics | $4.28 | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 10/06/2020 | AMGN | Buy Now | Amgen | $324.50 | -13.71% | $270 → $280 | Maintains | Outperform | Get Alert | |
| 09/21/2020 | MRTX | Buy Now | Mirati Therapeutics | — | — | $133 → $190 | Maintains | Outperform | Get Alert | |
| 07/21/2020 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.02 | 55.46% | $53 → $42 | Maintains | Perform | Get Alert | |
| 07/14/2020 | FREQ | Buy Now | Frequency Therapeutics | — | — | → $36 | Initiates | → Outperform | Get Alert | |
| 07/09/2020 | PRTA | Buy Now | Prothena Corp | $9.97 | — | — | Upgrade | Perform → Outperform | Get Alert | |
| 06/29/2020 | ICPT | Buy Now | Intercept Pharma | — | — | $124 → $46 | Downgrade | Outperform → Perform | Get Alert | |
| 06/24/2020 | KRTX | Buy Now | Karuna Therapeutics | — | — | $125 → $135 | Maintains | Outperform | Get Alert | |
| 06/12/2020 | BCYC | Buy Now | Bicycle Therapeutics | $7.40 | 264.86% | → $27 | Initiates | → Outperform | Get Alert | |
| 06/02/2020 | AYLA | Buy Now | Ayala Pharmaceuticals | — | — | → $23 | Initiates | → Outperform | Get Alert | |
| 05/27/2020 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.02 | 96.17% | $48 → $53 | Maintains | Perform | Get Alert | |
| 05/18/2020 | NKTR | Buy Now | Nektar Therapeutics | $58.80 | -57.48% | $24 → $25 | Maintains | Perform | Get Alert | |
| 05/01/2020 | AMGN | Buy Now | Amgen | $324.50 | -22.34% | $250 → $252 | Maintains | Outperform | Get Alert | |
| 04/28/2020 | KRTX | Buy Now | Karuna Therapeutics | — | — | → $125 | Initiates | → Outperform | Get Alert | |
| 04/27/2020 | AMGN | Buy Now | Amgen | $324.50 | -22.96% | $240 → $250 | Maintains | Outperform | Get Alert | |
| 04/23/2020 | BIIB | Buy Now | Biogen | $175.74 | 107.69% | $390 → $365 | Maintains | Outperform | Get Alert | |
| 04/21/2020 | INCY | Buy Now | Incyte | $99.08 | 13.04% | $90 → $112 | Maintains | Outperform | Get Alert | |
| 04/13/2020 | NBIX | Buy Now | Neurocrine Biosciences | $155.00 | -16.13% | $132 → $130 | Maintains | Outperform | Get Alert | |
| 04/08/2020 | SAGE | Buy Now | Sage Therapeutics | — | — | $60 → $50 | Maintains | Outperform | Get Alert | |
| 04/07/2020 | INCY | Buy Now | Incyte | $99.08 | -9.16% | $85 → $90 | Maintains | Outperform | Get Alert | |
| 04/07/2020 | MLND | Buy Now | Millendo Therapeutics | — | — | $25 → $2 | Downgrade | Outperform → Perform | Get Alert | |
| 03/30/2020 | MRTX | Buy Now | Mirati Therapeutics | — | — | $129 → $105 | Maintains | Outperform | Get Alert | |
| 03/26/2020 | AMGN | Buy Now | Amgen | $324.50 | -26.04% | $250 → $240 | Maintains | Outperform | Get Alert | |
| 02/06/2020 | VYGR | Buy Now | Voyager Therapeutics | $4.28 | 507.48% | → $26 | Initiates | → Outperform | Get Alert | |
| 01/13/2020 | NBIX | Buy Now | Neurocrine Biosciences | $155.00 | -14.84% | $115 → $132 | Maintains | Outperform | Get Alert | |
| 01/10/2020 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | $40 → $17 | Downgrade | Outperform → Perform | Get Alert | |
| 01/03/2020 | INCY | Buy Now | Incyte | $99.08 | -3.11% | $100 → $96 | Maintains | Outperform | Get Alert | |
| 12/20/2019 | MRNS | Buy Now | Marinus Pharma | — | — | → $6 | Initiates | → Outperform | Get Alert | |
| 12/09/2019 | ETNB | Buy Now | 89bio | — | — | → $60 | Initiates | → Outperform | Get Alert | |
| 12/06/2019 | SRRA | Buy Now | Sierra Oncology | — | — | → $1.2 | Initiates | → Outperform | Get Alert | |
| 11/25/2019 | CBAY | Buy Now | CymaBay Therapeutics | — | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 11/25/2019 | MDCO | Buy Now | Medicines Co | — | — | $68 → $85 | Downgrade | Outperform → Perform | Get Alert | |
| 10/24/2019 | NKTR | Buy Now | Nektar Therapeutics | $58.80 | -69.39% | → $18 | Initiates | → Perform | Get Alert | |
| 10/24/2019 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.02 | 62.86% | → $44 | Initiates | → Perform | Get Alert | |
| 09/05/2019 | INCY | Buy Now | Incyte | $99.08 | 0.93% | $85 → $100 | Upgrade | Perform → Outperform | Get Alert | |
| 09/03/2019 | MDCO | Buy Now | Medicines Co | — | — | $52 → $60 | Maintains | Outperform | Get Alert | |
| 08/13/2019 | MLND | Buy Now | Millendo Therapeutics | — | — | $26 → $25 | Maintains | Outperform | Get Alert | |
| 08/13/2019 | AMGN | Buy Now | Amgen | $324.50 | -29.12% | $210 → $230 | Maintains | Outperform | Get Alert | |
| 07/16/2019 | MLND | Buy Now | Millendo Therapeutics | — | — | → $26 | Initiates | → Outperform | Get Alert | |
| 11/19/2018 | ICPT | Buy Now | Intercept Pharma | — | — | → $140 | Upgrade | Perform → Outperform | Get Alert | |
| 08/08/2018 | ENTA | Buy Now | Enanta Pharma | $14.87 | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 07/18/2018 | INCY | Buy Now | Incyte | $99.08 | -29.35% | $65 → $70 | Maintains | Perform | Get Alert | |
| 06/01/2018 | MDGL | Buy Now | Madrigal Pharmaceuticals | $560.55 | — | — | Upgrade | Perform → Outperform | Get Alert | |
| 05/24/2018 | ENTA | Buy Now | Enanta Pharma | $14.87 | 807.87% | → $135 | Initiates | → Outperform | Get Alert | |
| 04/24/2018 | PRTA | Buy Now | Prothena Corp | $9.97 | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 04/17/2018 | MDGL | Buy Now | Madrigal Pharmaceuticals | $560.55 | -76.81% | → $130 | Initiates | → Perform | Get Alert | |
| 03/20/2018 | MDWD | Buy Now | MediWound | $19.05 | -37.01% | $10 → $12 | Maintains | Outperform | Get Alert | |
| 01/31/2018 | ACOR | Buy Now | Acorda Therapeutics | — | — | $18 → $21 | Maintains | Perform | Get Alert | |
| 01/26/2018 | BIIB | Buy Now | Biogen | $175.74 | 127.61% | $380 → $400 | Maintains | Outperform | Get Alert | |
| 11/30/2017 | MDCO | Buy Now | Medicines Co | — | — | — | Upgrade | Perform → Outperform | Get Alert | |
| 11/09/2017 | ACOR | Buy Now | Acorda Therapeutics | — | — | → $27 | Initiates | → Perform | Get Alert | |
| 11/09/2017 | BIIB | Buy Now | Biogen | $175.74 | 99.16% | → $350 | Initiates | → Outperform | Get Alert | |
| 11/02/2017 | NBIX | Buy Now | Neurocrine Biosciences | $155.00 | -45.16% | $70 → $85 | Maintains | Outperform | Get Alert | |
| 09/22/2017 | ICPT | Buy Now | Intercept Pharma | — | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 07/11/2017 | TXMD | Buy Now | TherapeuticsMD | $1.84 | — | — | Upgrade | Perform → Outperform | Get Alert | |
| 06/23/2017 | CBAY | Buy Now | CymaBay Therapeutics | — | — | → $8 | Initiates | → Outperform | Get Alert | |
| 06/14/2017 | NDRM | Buy Now | NeuroDerm Ltd. - Ordinary Shares | — | — | → $42 | Upgrade | Perform → Outperform | Get Alert | |
| 05/22/2017 | MDCO | Buy Now | Medicines Co | — | — | → $50 | Initiates | → Perform | Get Alert | |
| 05/12/2017 | INCY | Buy Now | Incyte | $99.08 | 26.16% | → $125 | Initiates | → Market Perform | Get Alert | |
| 05/09/2017 | TXMD | Buy Now | TherapeuticsMD | $1.84 | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 03/07/2017 | NDRM | Buy Now | NeuroDerm Ltd. - Ordinary Shares | — | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 02/24/2017 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | — | Upgrade | Perform → Outperform | Get Alert | |
| 01/27/2017 | NBIX | Buy Now | Neurocrine Biosciences | $155.00 | — | — | Upgrade | Perform → Outperform | Get Alert | |
| 01/19/2017 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | → $28 | Initiates | → Perform | Get Alert | |
| 12/13/2016 | AMGN | Buy Now | Amgen | $324.50 | -48.84% | → $166 | Initiates | → Outperform | Get Alert | |
| 11/22/2016 | TXMD | Buy Now | TherapeuticsMD, Inc. Common Stock | $1.84 | 552.17% | → $12 | Initiates | → Outperform | Get Alert | |
| 11/22/2016 | NBIX | Buy Now | Neurocrine Biosciences | $155.00 | -64.52% | → $55 | Initiates | → Perform | Get Alert | |
| 08/05/2016 | ICPT | Buy Now | Intercept Pharma | — | — | $265 → $250 | Maintains | Outperform | Get Alert | |
| 06/14/2016 | MRNS | Buy Now | Marinus Pharma | — | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 03/10/2016 | ZFC | Buy Now | ZAIS Financial | — | — | $17 → $16 | Maintains | Outperform | Get Alert | |
| 03/09/2016 | IILG | Buy Now | Interval Leisure Group | — | — | — | Initiates | → Outperform | Get Alert | |
| 02/12/2016 | INCY | Buy Now | Incyte | $99.08 | 9% | $129 → $108 | Maintains | Outperform | Get Alert | |
| 04/27/2015 | BIIB | Buy Now | Biogen | $175.74 | — | — | Assumes | → Perform | Get Alert | |
| 02/23/2015 | INCY | Buy Now | Incyte | $99.08 | -10.17% | $75 → $89 | Maintains | Outperform | Get Alert | |
| 09/09/2014 | MRNS | Buy Now | Marinus Pharma | — | — | → $12 | Initiates | → Outperform | Get Alert | |
| 07/11/2014 | PRTA | Buy Now | Prothena Corp | $9.97 | 301.2% | → $40 | Initiates | → Outperform | Get Alert | |
| 07/10/2014 | PRTA | Buy Now | Prothena Corp | $9.97 | 301.2% | → $40 | Initiates | → Outperform | Get Alert | |
| 01/10/2014 | ICPT | Buy Now | Intercept Pharma | — | — | $94 → $360 | Maintains | Outperform | Get Alert | |
| 08/02/2013 | INCY | Buy Now | Incyte | $99.08 | -71.74% | $25 → $28 | Maintains | Outperform | Get Alert | |
| 06/20/2013 | ICPT | Buy Now | Intercept Pharma | — | — | → $60 | Initiates | → Outperform | Get Alert | |
| 06/20/2013 | MDCO | Buy Now | Medicines Co | — | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 06/18/2013 | NBIX | Buy Now | Neurocrine Biosciences | $155.00 | -89.68% | → $16 | Initiates | → Outperform | Get Alert | |
| 01/03/2013 | BIIB | Buy Now | Biogen | $175.74 | -19.77% | $145 → $141 | Maintains | Perform | Get Alert | |
| 11/19/2012 | MDCO | Buy Now | Medicines Co | — | — | → $35 | Initiates | → Outperform | Get Alert | |
| 10/24/2012 | AMGN | Buy Now | Amgen | $324.50 | -72.57% | $85 → $89 | Maintains | Perform | Get Alert | |
| 10/04/2012 | BIIB | Buy Now | Biogen | $175.74 | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 05/01/2012 | BIIB | Buy Now | Biogen Idec | $175.74 | -20.91% | $136 → $139 | Maintains | Outperform | Get Alert | |
| 04/25/2012 | BIIB | Buy Now | Biogen Idec | $175.74 | -22.61% | $127 → $136 | Maintains | Outperform | Get Alert | |
| 02/09/2012 | AMGN | Buy Now | Amgen | $324.50 | — | — | Downgrade | Outperform → Perform | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved